CAS 1375469-38-7

BAY1082439

CAS : 1375469-38-7

BAY1082439

Degré de pureté : ≥98%

Masse moléculaire : 494.54g/mol

Ref: 54-BUP02028

BAY1082439

CAS : 1375469-38-7

BAY1082439, an orally bioavailable, selective inhibitor of PI3Kα/β/δ, demonstrates high efficacy in inhibiting the growth of Pten-null prostate cancer [1][2].

Formule : C₂₅H₃₀N₆O₅

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 494.54

Ref: TM-T14511

(R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylnicotinamide

CAS : 1375469-38-7

(R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)-2-methylnicotinamide is a ligand that binds to the GABA receptor. It is a potent inhibitor of the receptor and has been shown to alter neuronal activity. The inhibition of the GABA receptor by (R)-N-(8-(2-Hydroxy-3-morpholinopropoxy)-7-methoxy-2,3-dihydroimidazo[1,2c]quinazolin--5yl)-2methylnicotinamide may be responsible for its anticonvulsant properties. This compound also inhibits protein interactions with receptors and ion channels.

Formule : C₂₅H₃₀N₆O₅

Degré de pureté : Min. 95%

Masse moléculaire : 494.5 g/mol

Ref: 3D-AFC46938